In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...